Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson’s disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson’s disease
Authors
Keywords
-
Journal
NEUROLOGICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-01
DOI
10.1007/s10072-018-3628-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real life evaluation of safinamide effectiveness in Parkinson’s disease
- (2018) Francesca Mancini et al. NEUROLOGICAL SCIENCES
- Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study
- (2018) Claudio Liguori et al. PARKINSONISM & RELATED DISORDERS
- Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients
- (2018) Claudio Liguori et al. SLEEP MEDICINE
- Structural and Functional Brain Patterns of Non-Motor Syndromes in Parkinson’s Disease
- (2018) Tino Prell Frontiers in Neurology
- Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease
- (2017) I. Cova et al. PARKINSONISM & RELATED DISORDERS
- Effects of Safinamide on Pain in Fluctuating Parkinson’s Disease Patients: A Post-Hoc Analysis
- (2017) Carlo Cattaneo et al. Journal of Parkinsons Disease
- Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson’s Disease
- (2017) Carlo Cattaneo et al. Journal of Parkinsons Disease
- Safinamide: First Global Approval
- (2015) Emma D. Deeks DRUGS
- Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases
- (2015) Fabrizio Gardoni et al. Frontiers in Cellular Neuroscience
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys
- (2013) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Managing the patient with newly diagnosed Parkinson disease
- (2012) C. SINGER CLEVELAND CLINIC JOURNAL OF MEDICINE
- New pharmacological avenues for the treatment ofl-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors
- (2012) Fabio Blandini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Monoamine Oxidase B Inhibitors for the Treatment of Parkinsonʼs Disease
- (2011) Anthony H.V. Schapira CNS DRUGS
- Lights and Shadows on Monoamine Oxidase Inhibition in Neuroprotective Pharmacological Therapies
- (2011) Claudia Binda et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Safinamide in the treatment of Parkinson's disease
- (2010) Anthony HV Schapira EXPERT OPINION ON PHARMACOTHERAPY
- Levodopa: Past, Present, and Future
- (2009) Robert A. Hauser EUROPEAN NEUROLOGY
- Non-motor symptoms in Parkinson’s disease
- (2009) Ariane Park et al. JOURNAL OF NEUROLOGY
- Quantitation of non-motor symptoms in Parkinson’s disease
- (2008) K. Ray Chaudhuri et al. EUROPEAN JOURNAL OF NEUROLOGY
- An expert opinion on safinamide in Parkinson's disease
- (2008) Marco Onofrj et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now